Hyperhomocysteinemia. An emerging and important risk factor for thromboembolic and cardiovascular disease.

PubWeight™: 2.24‹?› | Rank: Top 2%

🔗 View Article (PMID 8980346)

Published in Am J Clin Pathol on December 01, 1996

Authors

S C Guba1, L M Fink, V Fonseca

Author Affiliations

1: Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, USA.

Articles by these authors

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA (1998) 5.91

Effect of troglitazone in insulin-treated patients with type II diabetes mellitus. Troglitazone and Exogenous Insulin Study Group. N Engl J Med (1998) 3.74

Neutralizing antibody responses to human immunodeficiency virus type 1 in primary infection and long-term-nonprogressive infection. J Infect Dis (1997) 3.35

Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study. Diabetologia (2009) 2.98

Persistence of parathyroid hypersecretion after vitamin D treatment in Asian vegetarians. J Clin Endocrinol Metab (1984) 2.86

Neutralizing and infection-enhancing antibody responses to human immunodeficiency virus type 1 in long-term nonprogressors. J Infect Dis (1996) 2.84

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. Diabetes Obes Metab (2009) 2.04

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study. Diabetologia (2009) 2.04

Lipid-sugar interactions : relevance to anhydrous biology. Plant Physiol (1988) 1.98

Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year study. Diabetes Obes Metab (2010) 1.76

Electrolyte disturbances and cardiac failure with hypomagnesaemia in anorexia nervosa. Br Med J (Clin Res Ed) (1985) 1.60

Plasma D-dimer: a useful tool for evaluating suspected pulmonary embolus. J Nucl Med (1993) 1.59

Thromboembolism in patients undergoing thoracotomy. Ann Thorac Surg (1993) 1.53

Antisperm antibody binding to human acrosin: a study of patients with unexplained infertility. Fertil Steril (1991) 1.39

Radioactivity in organs of patients receiving radioisotopes: a retraction. N Engl J Med (1977) 1.38

Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials. Diabet Med (2008) 1.37

An alteration in the phosphorylation of vimentin-type intermediate filaments is associated with mitosis in cultured mammalian cells. Cell (1982) 1.35

In vitro correlates of transformation in C3H/10T1/2 clone 8 mouse cells. Cancer Res (1976) 1.33

Removal of basement membrane in the involuting breast. Lab Invest (1976) 1.27

Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol (1986) 1.21

Effect of N-2-acetylaminofluorene modification on the conformation of nucleic acids. Cancer Res (1974) 1.12

Impaired vascular reactivity in African-American patients with type 2 diabetes mellitus and microalbuminuria or proteinuria despite angiotensin-converting enzyme inhibitor therapy. J Clin Endocrinol Metab (2005) 1.08

Exposure to sunlight and vitamin D deficiency in Saudi Arabian women. Postgrad Med J (1984) 1.05

Is the loss of endothelial thrombomodulin involved in the mechanism of chronicity in late radiation enteropathy? Radiother Oncol (1997) 1.05

Localization of the beta chain of human chorionic gonadotropin on human tumor cells and placental cells. Cancer Res (1975) 1.02

Hyperparathyroidism and low serum osteocalcin despite vitamin D replacement in primary biliary cirrhosis. J Clin Endocrinol Metab (1987) 1.01

Hirudin ameliorates intestinal radiation toxicity in the rat: support for thrombin inhibition as strategy to minimize side-effects after radiation therapy and as countermeasure against radiation exposure. J Thromb Haemost (2004) 0.99

Size of pancreas in diabetes mellitus: a study based on ultrasound. Br Med J (Clin Res Ed) (1985) 0.98

Acid and gastrin levels following pyloric-preserving pancreaticoduodenectomy. Arch Surg (1986) 0.98

In vitro plasminogen activator activity in human brain tumors. Cancer Res (1978) 0.97

Increased serum pancreatic enzymes after treatment with methylprednisolone: possible evidence of subclinical pancreatitis. Br Med J (Clin Res Ed) (1985) 0.96

Plasma creatinine and creatinine clearance in nutritional osteomalacia. Lancet (1984) 0.96

Hyperosmolar non-ketotic diabetic syndrome precipitated by treatment with diuretics. Br Med J (Clin Res Ed) (1982) 0.95

Blood S-adenosylmethionine concentrations and lymphocyte methylenetetrahydrofolate reductase activity in diabetes mellitus and diabetic nephropathy. Metabolism (2001) 0.95

Hypoalbuminaemic hyponatraemia: a new syndrome? Br Med J (Clin Res Ed) (1985) 0.94

Modifications of ribonucleic acid by chemical carcinogens. I. In vitro modification of transfer ribonucleic acid by N-acetoxy-2-acetylaminofluorene. Biochemistry (1970) 0.94

Painful diabetic neuropathy. Lancet (1985) 0.93

Osteopenia in women with anorexia nervosa. N Engl J Med (1985) 0.92

Insulin receptor antibodies causing steroid responsive diabetes mellitus in a patient with myositis. Br Med J (Clin Res Ed) (1984) 0.92

Circulating thrombomodulin during radiation therapy of lung cancer. Radiat Oncol Investig (1999) 0.91

Comparative studies on mammalian and yeast phenylalanine transfer ribonucleic acids. Biochemistry (1971) 0.91

Rat liver phenylalanine tRNA: column purification and fluorescence studies. Biochem Biophys Res Commun (1968) 0.89

Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism (1996) 0.88

The effect of modification of T7 DNA by the carcinogen N-1-acetylaminofluorene: termination of transcription in vitro. Biochemistry (1975) 0.87

Asymmetric distribution of plasma membrane proteins in mouse L-929 cells. Proc Natl Acad Sci U S A (1979) 0.87

Assessing anthropogenic pressures on estuarine fish nurseries along the Portuguese coast: a multi-metric index and conceptual approach. Sci Total Environ (2007) 0.87

Increased serum homocysteine and sudden death resulting from coronary atherosclerosis with fibrous plaques. Arterioscler Thromb Vasc Biol (2002) 0.86

Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism (1998) 0.85

Identification of transmembrane bridging proteins in the plasma membrane of cultured mouse L cells. Proc Natl Acad Sci U S A (1977) 0.85

Secondary hyperparathyroidism and bone density. Br Med J (Clin Res Ed) (1985) 0.85

Active morbidity surveillance after Hurricane Andrew--Florida, 1992. JAMA (1993) 0.85

Diarrhea and metformin in a diabetic clinic. Diabetes Care (1989) 0.84

Cytokines in coagulation and thrombosis: a preclinical and clinical review. Blood Coagul Fibrinolysis (2002) 0.84

Effect of troglitazone on fibrinolysis and activated coagulation in patients with non-insulin-dependent diabetes mellitus. J Diabetes Complications (1998) 0.82

Acute adrenal crisis precipitated by thyroxine. Br Med J (Clin Res Ed) (1986) 0.82

The effect of glucose and insulin on the activity of methylene tetrahydrofolate reductase and cystathionine-beta-synthase: studies in hepatocytes. Atherosclerosis (2001) 0.82

Effects of perfluorochemical on phagocytic function of leukocytes. Transfusion (1984) 0.82

Young women with advanced aortoiliac occlusive disease: new insights. Ann Vasc Surg (1996) 0.82

Differential effect of radiation on endothelial cell function in rectal cancer and normal rectum. Am J Surg (1998) 0.82

Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy. Hernia (2005) 0.82

Chemical carcinogens and RNA. Cancer Res (1971) 0.81

Collagen-binding of von Willebrand's factor antigen in the classification of von Willebrand's disease. Am J Clin Pathol (1987) 0.81

Management of the insulin resistance syndrome. Curr Diab Rep (2001) 0.81

Latent choriocarcinoma. Cancer (1967) 0.81

Acute painful diabetic neuropathy. Diabetes Care (1988) 0.81

Advanced prostate cancer activates coagulation: a controlled study of activation markers of coagulation in ambulatory patients with localized and advanced prostate cancer. Blood Coagul Fibrinolysis (2002) 0.80

Effect of perfluorochemical blood substitutes on human neutrophil function. Transfusion (1984) 0.80

cDNA cloning and sequencing, gene expression, and immunolocalization of thrombomodulin in the Sprague-Dawley rat. DNA Res (1999) 0.80

Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis. Endocr Rev (1999) 0.80

Hyperhomocysteinemia and thrombosis. Semin Thromb Hemost (1999) 0.79

New treatment approaches to myasthenia gravis. Drugs (1990) 0.79

Association between decreased pulmonary endothelial cell thrombomodulin and local fibrin deposition in pneumonia. Blood Coagul Fibrinolysis (2001) 0.78

Proliferative retinopathy and diabetes mellitus. Lancet (1984) 0.78

Biochemical abnormalities in anorexia nervosa and bulimia. Ann Clin Biochem (1987) 0.78

Reproducibility of creatine kinase isoenzyme electrophoresis. Clin Chem (1989) 0.78

beta-blocker use and diabetes symptom score: results from the GEMINI study. Diabetes Obes Metab (2007) 0.78

Thiazolidinediones and congestive heart failure in veterans with type 2 diabetes. Diabetes Obes Metab (2011) 0.78

Is testing for inherited coagulation inhibitor deficiencies in young stroke patients worthwhile? Clin Neurol Neurosurg (2000) 0.77

Perfluorochemicals. Morphologic changes in infused liver, spleen, lung, and kidney of rabbits. Arch Pathol Lab Med (1984) 0.77

Pancreas in non-insulin dependent diabetics. Lancet (1985) 0.77

Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model. J Vasc Surg (1998) 0.77

Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens. Prog Clin Pathol (1984) 0.77

Diagnosis and treatment of hyperhomocysteinemia. Curr Atheroscler Rep (2001) 0.76

Platelet aggregation and thromboxane A2 release in primary biliary cirrhosis and effect of D-penicillamine treatment. Prostaglandins Leukot Essent Fatty Acids (1988) 0.76

Rapid preparation of plasma for coagulation testing. Arch Pathol Lab Med (1991) 0.76

A comparison of long-term survivals of simultaneous pancreas-kidney transplant between African American and Caucasian recipients with basiliximab induction therapy. Am J Transplant (2007) 0.76

An automated method for the analysis of T-cell receptor repertoires. Rapid RT-PCR fragment length analysis of the T-cell receptor beta chain complementarity-determining region 3. Am J Clin Pathol (1999) 0.76

Hyperhomocysteinemia and premature vascular occlusive disease. Am J Med Sci (1998) 0.76

Loss of heterozygosity and overexpression of p53 gene in human primary prostatic adenocarcinoma. Diagn Mol Pathol (1994) 0.76

Serum immunoreactive trypsin and pancreatic lipase in primary biliary cirrhosis. J Clin Pathol (1986) 0.75

Association of hyperglycaemia with hyponatraemia. Br Med J (Clin Res Ed) (1984) 0.75

Hyperhomocysteinemia and microalbuminuria in diabetes. Diabetes Care (1998) 0.75

Lisinopril and nifedipine administration inhibits the ex vivo uptake of [45Ca2+] by platelets from hypertensive diabetic patients. Br J Clin Pharmacol (1992) 0.75

Thrombomodulin staining of mesothelioma cells. Hum Pathol (1992) 0.75

Changes in glucose tolerance after treatment for acromegaly. BMJ (1989) 0.75

Vitamin D deficiency after vagotomy. Br Med J (Clin Res Ed) (1985) 0.75

Pulmonary embolism. N Engl J Med (1998) 0.75

Pituitary apoplexy. Br Med J (Clin Res Ed) (1985) 0.75